C22ORF15 Antikörper (AA 61-148) (Biotin)

Produktnummer ABIN1699899

Dieses Anti-C22ORF15-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von C22ORF15 in WB, ELISA, IHC (fro) und IHC (p). Geeignet für Human.

Kurzübersicht für C22ORF15 Antikörper (AA 61-148) (Biotin) (ABIN1699899)

Target: C22ORF15 (Chromosome 22 Open Reading Frame 15 (C22ORF15))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser C22ORF15 Antikörper ist konjugiert mit Biotin

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Produktdetails anti-C22ORF15 Antikörper (Biotin)

Bindungsspezifität: AA 61-148

Homologie: Human

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C22orf15

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu C22ORF15

Target: C22ORF15 (Chromosome 22 Open Reading Frame 15 (C22ORF15))

Andere Bezeichnung: C22orf15

Hintergrund:

Synonyms: C22orf15, chromosome 22 open reading frame 15, CV015_HUMAN, N27C7 3, Protein N27C7-3, Uncharacterized protein C22orf15.

Background: Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia. The C22orf15 gene product has been provisionally designated C22orf15 pending further characterization.

Gen-ID: 150248